Cart
sales@molnova.com
Ganolucidic acid B
CAS No. 98683-75-1
Ganolucidic acid B( —— )
Catalog No. M32486 CAS No. 98683-75-1
Ganolucidic acids B showd induction ability of hPXR-mediated CYP3A4 expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 691 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameGanolucidic acid B
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanolucidic acids B showd induction ability of hPXR-mediated CYP3A4 expression.
-
DescriptionGanolucidic acids B showd induction ability of hPXR-mediated CYP3A4 expression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98683-75-1
-
Formula Weight502.7
-
Molecular FormulaC30H46O6
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
RGD-4C
RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the recognition specificity of the matrix proteins. RGD-4C is a αv-integrin ligand, can conjugate with bioactive molecule to exert antitumor effects in animal models.
-
4-Hydroxy-3-methoxym...
Vanillyl mandelic acid (VMA) is a chemical intermediate in the synthesis of artificial vanilla flavorings and is an end-stage metabolite of the catecholamines, epinephrine, and norepinephrine.
-
Fletikumab
Fletikumab (NNC0109-0012) is a monoclonal antibody that inhibits IL-20, primarily used in research on rheumatoid arthritis and psoriasis.
